Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone PCIA with Five Elements Music Therapy for Moderate to Severe Cancer Pain
ChiCTR2300076805Phase 4Not yet recruiting
- Sponsor
- Shanxi Academy of Traditional Chinese Medicine
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in cancer pain (2 arms), sponsored by Shanxi Academy of Traditional Chinese Medicine. Primary endpoint: Clinical success rate (pain relief ≥50%). Planned start Nov 2023; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2300076805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076805.